Soundview Dialysis Center Bronx, NY - 10473

Soundview Dialysis Center is categorized under Kidney Dialysis Centers in Bronx, NY .

Soundview Dialysis Center was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214920 by the NAICS.

If you are seeking more information, feel free to contact Sharon Talbot, Administrator at the company’s single location by writing to 1622 Bruckner Boulevard, Bronx, New York NY 10473 or by phoning (718) 861-2334. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Soundview Dialysis Center
Contact Person: Sharon Talbot, Administrator
Address: 1622 Bruckner Boulevard, Bronx, New York 10473
Phone Number: (718) 861-2334
Website Address: davita.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 6214920
Share This Business:

Soundview Dialysis Center was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Sharon Talbot, Administrator for inquiries that concern Soundview Dialysis Center by calling the company number (718) 861-2334, as your correspondence is most welcome. Additionally, the physical location of the single location of Soundview Dialysis Center can be found at the coordinates 40.82392,-73.87423 as well as the street address 1622 Bruckner Boulevard in Bronx, New York 10473.

For its online presence, you may visit Soundview Dialysis Center’s website at davita.com and engage with its social media outlets through on Twitter and on Facebook.